Screening Mammography Rates in the Medicare Population before and after the 2009 U.S. Preventive Services Task Force Guideline Change: An Interrupted Time Series Analysis

Women's Health Issues

Volumn 25, Issue 3, 2015, Pages 239-245

  Jiang, Miao ^a,b   Hughes, Danny R ^a,b   Duszak, Richard ^a,c  

^a HARVEY L NEIMAN HEALTH POLICY INSTITUTE   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; EYE EXAMINATION; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAMMOGRAPHY; MEDICARE; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PRACTICE GUIDELINE; TIME SERIES ANALYSIS; UNITED STATES; VERY ELDERLY; BREAST NEOPLASMS; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; HEALTH SURVEY; LONGITUDINAL STUDY; MASS SCREENING; REGISTER; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA; TRENDS; UTILIZATION;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GUIDELINES AS TOPIC; HUMANS; INTERRUPTED TIME SERIES ANALYSIS; LONGITUDINAL STUDIES; MAMMOGRAPHY; MASS SCREENING; MEDICARE; PUBLIC HEALTH SURVEILLANCE; REGISTRIES; REGRESSION ANALYSIS; UNITED STATES;

EID: 84929076154     PISSN: 10493867     EISSN: 18784321     Source Type: Journal    
DOI: 10.1016/j.whi.2015.03.002     Document Type: Article

References (34)

1. American Optometric Association. (2014). Recommended eye examination frequency for pediatric patients and adults. Available: Accessed September 18,2014. http://www.aoa.org/patients-and-public/caring-for-your-vision/comprehensive-eye-and-vision-examination/recommended-examination-frequency-for-pediatric-patients-and-adults?sso=y.
2. Bleyer A., Welch H.G. Effect of three decades of screening mammography on breast-cancer incidence. New England Journal of Medicine 2012, 367(21):1998-2005.
3. Block L.D., Jarlenski M.P., Wu A.W., Bennett W.L. Mammography use among women ages 40-49 after the 2009 U.S. Preventive Services TaskForce recommendation. Journal of General Internal Medicine 2013, 28(11):1447-1453.
4. Centers for Medicare and Medicaid Services. (2012). Pap tests/pelvic exams (screening). Available: Accessed September 18,2014. http://www.medicare.gov/coverage/pap-tests-pelvic-exams-screening.html.
5. Elmore J.G., Armstrong K., Lehman C.D., Fletcher S.W. Screening for breast cancer. JAMA 2005, 293(10):1245-1256.
6. Gøtzsche P.C., Olsen O. Is screening for breast cancer with mammography justifiable?. Lancet 2000, 355(9198):129-134.
7. Hawton K., Bergen H., Simkin S., Brock A., Griffiths C., Romeri E., Gunnell D., et al. Effect of withdrawal of co-proxamol on prescribing and deaths from drug poisoning in England and Wales: Time series analysis. British Medical Journal 2009, 338(b2270):1-5.
8. Hawton K., Bergen H., Simkin S., Wells C., Kapur N., Gunnell D. Six-year follow-up of impact of co-proxamol withdrawal in England and Wales on prescribing and deaths: Time-series study. PLoS Medicine 2012, 9(5):e1001213.
9. Howard D.H., Adams E.K. Mammography rates after the 2009 US Preventive Services Task Force breast cancer screening recommendation. Preventive Medicine 2012, 55(5):485-487.
10. Humphrey L.L., Helfand M., Chan B.K., Woolf S.H. Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2002, 137(5 Part 1):347-360.
11. Jemal A., Center M.M., DeSantis C., Ward E.M. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology, Biomarkers & Prevention 2010, 19(8):1893-1907.
12. Jiang M., Hughes D.R., Appleton C.M., McGinty G., Duszak R. Recent trends in adherence to continuous screening for breast cancer among Medicare beneficiaries. Preventive Medicine 2015, 73C:47-52.
13. Kachalia A., Mello M.M. Breast cancer screening: Conflicting guidelines and medicolegal risk. JAMA 2013, 309(24):2555-2556.
14. Ma Z., Kuller L.H., Fisher M.A., Ostroff S.M. Use of interrupted time-series method to evaluate the impact of cigarette excise tax increases in Pennsylvania, 2000-2009. Preventing Chronic Disease 2013, 10:E169.
15. Michielutte R., Shelton B., Paskett E.D., Tatum C.M., Velez R. Use of an interrupted time-series design to evaluate a cancer screening program. Health Education Research 2000, 15(5):615-623.
16. National Cancer Institute. (2014). SEER cancer statistics review, 1975-2011. Bethesda, MD. Available: Accessed April 9, 2014. http://seer.cancer.gov/csr/1975_2011/.
17. Pace L.E., He Y., Keating N.L. Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer 2013, 119(14):2518-2523.
18. Penfold R.B., Zhang F. Use of interrupted time series analysis in evaluating health care quality improvements. Academic Pediatrics 2013, 13(6 Suppl):S38-S44.
19. Salloum R.G., Kohler R.E., Jensen G.A., Sheridan S.L., Carpenter W.R., Biddle A.K. U.S. Preventive Services Task Force recommendations and cancer screening among female Medicare beneficiaries. Journal of Women's Health (2002) 2014, 23(3):211-217.
20. Shadish W.R., Cook T.D., Campbell D.T. Experimental and quasi-experiment design for generalized causal inference 2002, Houghton Mifflin Company, Boston, MA.
21. Sharpe R.E., Levin D.C., Parker L., Rao V.M. The effect of the controversial US Preventive Services Task Force recommendations on the use of screening mammography. Journal of the American College of Radiology 2013, 10(1):21-24.
22. Smith R.A., Cokkinides V., von Eschenbach A.C., Levin B., Cohen C., Runowicz C.D., Eyre H.J., et al. American Cancer Society guidelines for the early detection of cancer. CA: A Cancer Journal for Clinicians 2002, 52(1):8-22.
23. Sprague B.L., Bolton K.C., Mace J.L., Herschorn S.D., James T.A., Vacek P.M., Geller B.M., et al. Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations. Radiology 2014, 270(2):354-361.
24. Tabár L., Duffy S.W., Vitak B., Chen H.H., Prevost T.C. The natural history of breast carcinoma: What have we learned from screening?. Cancer 1999, 86(3):449-462.
25. Screening for cervical cancer: recommendations and rationale. American Journal of Nursing 2003, 103(11):101-102. U.S. Preventive Services Task Force (USPSTF).
26. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine 2009, 151(10):716-726. U.S. Preventive Services Task Force (USPSTF).
27. U.S. Preventive Services Task Force (USPSTF). (2012). Screening for cervical cancer. Available: Accessed April 9, 2014. http://www.uspreventiveservicestaskforce.org/uspstf11/cervcancer/cervcancerrs.htm.
28. Wagner a K., Soumerai S.B., Zhang F., Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. Journal of Clinical Pharmacy and Therapeutics 2002, 27(4):299-309.
29. Walter L.C., Schonberg M.A. Screening mammography in older women: A review. JAMA 2014, 311(13):1336-1347.
30. Wang A.T., Fan J., Van Houten H.K., Tilburt J.C., Stout N.K., Montori V.M., Shah N.D. Impact of the 2009 US Preventive Services Task Force guidelines on screening mammography rates on women in their 40s. PLoS One 2014, 9(3):e91399.
31. Welch H.G. Screening mammography-A long run for a short slide?. New England Journal of Medicine 2010, 363(13):1276-1278.
32. Welch H.G., Hayes K.J., Frost C. Repeat testing among Medicare beneficiaries. Archives of Internal Medicine 2012, 172(22):1745-1751.
33. Zhang, F., Wagner, A., S. B., Soumerai, & Ross-Degnan, D. (2002). Estimating confidence intervals around relative changes in outcomes in segmented regression analyses of time series data. Available: http://www.lexjansen.com/nesug/nesug02/st/st005.pdf.
34. Zur J., Mojtabai R. Medicaid expansion initiative in Massachusetts: Enrollment among substance-abusing homeless adults. American Journal of Public Health 2013, 103(11):2007-2013.